1 March 2016 | Stratification using gender and body mass index (BMI) can predict side-effect risk in people with Type 2 diabetes initiating thiazolidinediones but not sulphonylureas: a MASTERMIND study | Dennis, JM; Hattersley, AT; Henley, WE; et al. |
1 March 2015 | Patients who develop oedema on initiating thiazolidinedione therapy have an improved glycaemic response: a MASTERMIND study | Dennis, JM; Hattersley, AT; Weedon, M; et al. |
1 September 2015 | Development of oedema is associated with an improved glycaemic response in patients initiating thiazolidinediones: a MASTERMIND study | Dennis, JM; Hattersley, AT; Weedon, M; et al. |
12 October 2017 | Cohort profile for the MASTERMIND study: Using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with Type 2 diabetes | Rodgers, LR; Weedon, MN; Henley, WE; et al. |
1 May 2019 | Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors | Warrington, NM; Beaumont, RN; Horikoshi, M; et al. |
6 April 2016 | Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c? | Jones, AG; Lonergan, M; Henley, WE; et al. |
21 April 2016 | Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic | Hope, SV; Knight, BA; Shields, BM; et al. |
14 March 2018 | Are the new drugs better? Changing UK prescribing of Type 2 diabetes medications and effects on HbA1c and weight, 2010 to 2016 | Dennis, JM; Henley, WE; Weedon, MN; et al. |
30 January 2018 | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic | Clissold, RL; Fulford, J; Hudson, M; et al. |
20 February 2018 | Genetic risk scores in adult-onset type 1 diabetes - Authors' reply | Thomas, NJ; Jones, SE; Weedon, MN; et al. |